AngioDynamics to Present at the J.P. Morgan Healthcare Conference
December 20 2018 - 4:01PM
Business Wire
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of
innovative, minimally invasive medical devices for vascular access,
peripheral vascular disease, and oncology, today announced that Jim
Clemmer, President and Chief Executive Officer, and Michael C.
Greiner, Executive Vice President and Chief Financial Officer, will
present at the 37th Annual J.P. Morgan Healthcare Conference at
3:00 p.m. PT on Tuesday, January 8, 2019 in San Francisco, CA.
A live webcast of the presentation and Q&A breakout session
will be accessible through the “Investors” section of the Company’s
website at www.angiodynamics.com and will be available for replay
following the event.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider
of innovative, minimally invasive medical devices used by
professional healthcare providers for vascular access, peripheral
vascular disease, and oncology. AngioDynamics’ diverse product
lines include market-leading ablation systems, fluid management
systems, vascular access products, angiographic products and
accessories drainage products, thrombolytic products and venous
products. For more information, visit www.angiodynamics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181220005716/en/
Investor Contact:AngioDynamics, Inc.Michael C. Greiner,
Executive Vice President & CFO(518) 795-1821
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Mar 2024 to Apr 2024
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Apr 2023 to Apr 2024